Pembrolizumab,Gemcitabine
Merck
['#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'thanks', 'merck']
pleased to share survival results of hcrngu14-188 at the rapid abstract session this morning. stop by our poster at #guasco23. thanks to my co-investigators and all the patients and families for support of the study 
GU Oncologist at @UHhospitals